DOW JONES23,719.37+285.80 1.22%
S&P 5002,789.82+39.84 1.45%
NASDAQ8,153.58+62.67 0.77%

Atossa Genetics Reports Will Meet With FDA On Apr. 30, 2020 To Discuss Clinical Development Of Oral Endoxifen To Reduce Mammographic Breast Density

Benzinga · 03/13/2020 12:33